Important work on follicular lymphomas published in NEJM
Erlend B. Smeland, Stein Kvaløy, Harald Holte and Jan Delabie contribute as co-authors to the publication "Predictionof survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells", published in the November issue of New England Journal of Medicine (impact factor 34.83).
Patients with follicular lymphoma may survive for periods of less than 1 year to more than 20 years after diagnosis. The authors have developed a method to find a molecular predictor of the length of survival by using gene-expression profiles of tumor-biopsy specimens. They conclude that the length of survival among patients with follicular lymphoma correlates with the molecular features of nonmalignant immune cells present in the tumor at diagnosis.
Link to article from PubMed
Patients with follicular lymphoma may survive for periods of less than 1 year to more than 20 years after diagnosis. The authors have developed a method to find a molecular predictor of the length of survival by using gene-expression profiles of tumor-biopsy specimens. They conclude that the length of survival among patients with follicular lymphoma correlates with the molecular features of nonmalignant immune cells present in the tumor at diagnosis.
Link to article from PubMed